Potential strategic alternatives that may be explored or evaluated as part of this review include a sale of the company, a reverse merger, a business ... ...read more
Growth Capitalist (https://growthcapitalist.com/2016/09/news-review-of-2-biotech-stocks-alexion-pharmaceuticals-inc-nasdaqalxn-tokai/)
Potential strategic alternatives that may be explored or evaluated as part of this review include a sale of the company, a reverse merger, a business ... ...read more